Follow the people · Insider
Jason B. Daly
Jason B. Daly files insider transactions with the SEC as an evp, chief legal officer of Amneal Pharmaceuticals (AMRX). We hold 2 disclosed purchases and sales filed since 3 March 2022, 2 of them in the last 90 days.
- Files forAMRX
- Disclosed buys and sells2 in all, 2 in the last 90 days
- Last disclosure13 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 3 March 2022 — 12 August 2026EVP, Chief Legal Officer · Amneal Pharmaceuticals (AMRX)70 Form 4 lines · source: SEC Form 4
Everything they disclosed
70 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 6,613 shares of Amneal PharmaceuticalsSEC Form 413 August 2026Class A Common Stock · traded 11 August 2026 · filed 13 August 2026
- ▼ sold on the open market 210,000 shares of Amneal PharmaceuticalsSEC Form 413 August 2026Class A Common Stock · traded 12 August 2026 · filed 13 August 2026
- exercised options over 22,645 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- had shares withheld for tax on 15,580 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 4 March 2026 · filed 5 March 2026
- exercised options over 22,645 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Restricted Stock Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 38,226 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Restricted Stock Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 24,258 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Restricted Stock Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 305,810 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Performance-Based Restricted Stock Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 35,880 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Restricted Stock Units · traded 4 March 2026 · filed 5 March 2026
- had shares withheld for tax on 10,147 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 38,226 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 22,645 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Restricted Stock Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 38,226 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Restricted Stock Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 24,258 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Restricted Stock Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 305,810 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Performance-Based Restricted Stock Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 35,880 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Restricted Stock Units · traded 4 March 2026 · filed 5 March 2026
- had shares withheld for tax on 16,598 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 24,258 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- had shares withheld for tax on 10,533 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 305,810 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- had shares withheld for tax on 132,783 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 22,645 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- had shares withheld for tax on 10,147 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 38,226 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- had shares withheld for tax on 16,598 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 24,258 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- had shares withheld for tax on 10,533 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 305,810 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- had shares withheld for tax on 132,783 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 35,880 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 4 March 2026 · filed 5 March 2026
- had shares withheld for tax on 15,580 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 4 March 2026 · filed 5 March 2026
- exercised options over 35,880 shares of Amneal PharmaceuticalsSEC Form 45 March 2026Class A Common Stock · traded 4 March 2026 · filed 5 March 2026
- was granted 65,359 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 43 March 2026Restricted Stock Units · traded 2 March 2026 · filed 3 March 2026
- was granted 65,359 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 43 March 2026Performance-Based Restricted Stock Units · traded 2 March 2026 · filed 3 March 2026
- was granted 65,359 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 43 March 2026Restricted Stock Units · traded 2 March 2026 · filed 3 March 2026
- was granted 65,359 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 43 March 2026Performance-Based Restricted Stock Units · traded 2 March 2026 · filed 3 March 2026
- ▼ sold on the open market 22,000 shares of Amneal PharmaceuticalsSEC Form 413 August 2025Class A Common Stock · traded 12 August 2025 · filed 13 August 2025
- ▼ sold on the open market 43,064 shares of Amneal PharmaceuticalsSEC Form 47 March 2025Class A Common Stock · traded 5 March 2025 · filed 7 March 2025
- ▼ sold on the open market 46,936 shares of Amneal PharmaceuticalsSEC Form 47 March 2025Class A Common Stock · traded 6 March 2025 · filed 7 March 2025
- exercised options over 22,645 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2025Restricted Stock Units · traded 3 March 2025 · filed 5 March 2025
- exercised options over 38,226 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2025Restricted Stock Units · traded 3 March 2025 · filed 5 March 2025
- exercised options over 90,580 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2025Performance-Based Restricted Stock Units · traded 3 March 2025 · filed 5 March 2025
- was granted 194,064 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2025Performance-Based Restricted Stock Units · traded 3 March 2025 · filed 5 March 2025
- was granted 97,032 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2025Restricted Stock Units · traded 3 March 2025 · filed 5 March 2025
- exercised options over 35,879 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2025Restricted Stock Units · traded 4 March 2025 · filed 5 March 2025
- exercised options over 22,645 shares of Amneal PharmaceuticalsSEC Form 45 March 2025Class A Common Stock · traded 3 March 2025 · filed 5 March 2025
- had shares withheld for tax on 6,943 shares of Amneal PharmaceuticalsSEC Form 45 March 2025Class A Common Stock · traded 3 March 2025 · filed 5 March 2025
- exercised options over 38,226 shares of Amneal PharmaceuticalsSEC Form 45 March 2025Class A Common Stock · traded 3 March 2025 · filed 5 March 2025
- had shares withheld for tax on 10,864 shares of Amneal PharmaceuticalsSEC Form 45 March 2025Class A Common Stock · traded 3 March 2025 · filed 5 March 2025
- exercised options over 90,580 shares of Amneal PharmaceuticalsSEC Form 45 March 2025Class A Common Stock · traded 3 March 2025 · filed 5 March 2025
- had shares withheld for tax on 31,338 shares of Amneal PharmaceuticalsSEC Form 45 March 2025Class A Common Stock · traded 3 March 2025 · filed 5 March 2025
- exercised options over 35,879 shares of Amneal PharmaceuticalsSEC Form 45 March 2025Class A Common Stock · traded 4 March 2025 · filed 5 March 2025
- had shares withheld for tax on 15,579 shares of Amneal PharmaceuticalsSEC Form 45 March 2025Class A Common Stock · traded 4 March 2025 · filed 5 March 2025
- ▼ sold on the open market 13,665 shares of Amneal PharmaceuticalsSEC Form 422 November 2024Class A Common Stock · traded 21 November 2024 · filed 22 November 2024
- ▼ sold on the open market 43,657 shares of Amneal PharmaceuticalsSEC Form 419 November 2024Class A Common Stock · traded 15 November 2024 · filed 19 November 2024
- exercised options over 22,645 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2024Restricted Stock Units · traded 3 March 2024 · filed 5 March 2024
- exercised options over 38,226 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2024Restricted Stock Units · traded 3 March 2024 · filed 5 March 2024
- was granted 143,519 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2024Restricted Stock Units · traded 4 March 2024 · filed 5 March 2024
- was granted 287,038 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 45 March 2024Performance-Based Restricted Stock Units · traded 4 March 2024 · filed 5 March 2024
- exercised options over 22,645 shares of Amneal PharmaceuticalsSEC Form 45 March 2024Class A Common Stock · traded 3 March 2024 · filed 5 March 2024
- had shares withheld for tax on 7,166 shares of Amneal PharmaceuticalsSEC Form 45 March 2024Class A Common Stock · traded 3 March 2024 · filed 5 March 2024
- exercised options over 38,226 shares of Amneal PharmaceuticalsSEC Form 45 March 2024Class A Common Stock · traded 3 March 2024 · filed 5 March 2024
- had shares withheld for tax on 10,864 shares of Amneal PharmaceuticalsSEC Form 45 March 2024Class A Common Stock · traded 3 March 2024 · filed 5 March 2024
- exercised options over 22,645 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 47 March 2023Restricted Stock Units · traded 3 March 2023 · filed 7 March 2023
- was granted 152,905 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 47 March 2023Restricted Stock Units · traded 3 March 2023 · filed 7 March 2023
- was granted 305,810 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 47 March 2023Performance-Based Restricted Stock Units · traded 3 March 2023 · filed 7 March 2023
- exercised options over 22,645 shares of Amneal PharmaceuticalsSEC Form 47 March 2023Class A Common Stock · traded 3 March 2023 · filed 7 March 2023
- had shares withheld for tax on 8,164 shares of Amneal PharmaceuticalsSEC Form 47 March 2023Class A Common Stock · traded 3 March 2023 · filed 7 March 2023
- was granted 90,580 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 43 March 2022Restricted Stock Units · traded 3 March 2022 · filed 3 March 2022
- was granted 181,160 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 43 March 2022Performance-Based Restricted Stock Units · traded 3 March 2022 · filed 3 March 2022
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.